001     141583
005     20240321221000.0
024 7 _ |a 10.5688/ajpe6891
|2 doi
024 7 _ |a pmid:31619813
|2 pmid
024 7 _ |a pmc:PMC6788147
|2 pmc
024 7 _ |a 0002-9459
|2 ISSN
024 7 _ |a 1553-6467
|2 ISSN
024 7 _ |a altmetric:68914528
|2 altmetric
037 _ _ |a DZNE-2020-07907
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Law, Ernest H
|b 0
245 _ _ |a The Role of Personality in Treatment-Related Outcome Preferences Among Pharmacy Students.
260 _ _ |a Des Moines, Iowa
|c 2019
|b Assoc.
264 _ 1 |3 online
|2 Crossref
|b American Journal of Pharmaceutical Education
|c 2019-09-01
264 _ 1 |3 print
|2 Crossref
|b American Journal of Pharmaceutical Education
|c 2019-09-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1688391106_14565
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Objective. To examine whether personality traits, particularly conscientiousness and agreeableness, were associated with systematic differences in health outcome preferences in cancer treatment scenarios among second-year Doctor of Pharmacy students. Methods. An online survey that quantified outcome preferences using profile best-worst scaling tasks was administered to pharmacy students (n=185). The Big Five personality inventory was used to categorize respondents into tertile-based levels of each trait. Treatment-related health outcomes were described using the EQ-5D-Y system and framed with hypothetical cancer treatment scenarios. Preferences were obtained using count analysis for each treatment-related outcome, and differences based on the level of trait were tested using analysis of variance. Logistic regression was used to test for significant associations between higher levels of a trait and choosing dead over a severe health state. Results. Higher conscientiousness was associated with students who had an approximately 20% more positive preference for 'no problems' in the Usual Activities and Pain/Discomfort attributes, as well as a 19% more negative preference for 'a lot of problems' in the Pain/Discomfort attribute. No differences in treatment preferences were observed across agreeableness tertiles. Higher levels of personality traits were not significantly associated with choosing death over being in moderate health. Conclusion. Conscientiousness appears to be a factor in treatment-related outcome preferences among pharmacy students. Individuals with higher levels of conscientiousness may be more likely to recommend treatments that are less likely to cause pain or discomfort and negatively impact a patient's usual activities.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Education, Pharmacy
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Neoplasms: therapy
|2 MeSH
650 _ 2 |a Patient Preference
|2 MeSH
650 _ 2 |a Personality
|2 MeSH
650 _ 2 |a Students, Pharmacy: psychology
|2 MeSH
650 _ 2 |a Surveys and Questionnaires
|2 MeSH
650 _ 2 |a Treatment Outcome
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
700 1 _ |a Jiang, Ruixuan
|b 1
700 1 _ |a Rädke, Anika
|0 P:(DE-2719)9001134
|b 2
|u dzne
700 1 _ |a Mühlbacher, Axel
|b 3
700 1 _ |a Pickard, A Simon
|b 4
773 1 8 |a 10.5688/ajpe6891
|b : American Journal of Pharmaceutical Education, 2019-09-01
|n 7
|p 6891
|3 journal-article
|2 Crossref
|t American Journal of Pharmaceutical Education
|v 83
|y 2019
|x 0002-9459
773 _ _ |a 10.5688/ajpe6891
|g Vol. 83, no. 7, p. ajpe6891 -
|0 PERI:(DE-600)2140035-0
|n 7
|q 83:7|p 6891
|t American journal of pharmaceutical education
|v 83
|y 2019
|x 0002-9459
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788147
909 C O |p VDB
|o oai:pub.dzne.de:141583
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9001134
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-15
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AM J PHARM EDUC : 2021
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-15
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-15
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-15
920 1 _ |0 I:(DE-2719)5000001
|k AG Grabe
|l Biomarkers of Dementia in the General Population
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000001
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21